Staar Surgical Aqua-Flow

Premarket approval application submission for the collagen glaucoma drainage device is announced July 6. Clinical data included in the filing show a mean reduction of intraocular pressure from 24.2 mm Hg before placement to 16.5 mm Hg at one-year follow-up. Patients also experienced a mean drop in pressure controlling medications from 2.3 to 0.3, the firm says. Physician training is scheduled to begin in August